Prph Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Peripherin (encoded by the PRPH gene) is a type III neuronal intermediate filament protein essential for the structure, function, and maintenance of peripheral neurons. It is expressed predominantly in the peripheral nervous system and plays critical roles in axonal transport, neurite outgrowth, and neuronal survival. PRPH mutations have been implicated in amyotrophic lateral sclerosis (ALS) and neuronal intermediate filament inclusion disease (NIFID), highlighting its importance in neurodegenerative processes[1].
PRPH (Peripherin) is a gene on chromosome 21q22.2 encoding a type III neuronal intermediate filament protein essential for the structure, function, and maintenance of peripheral neurons. It is expressed predominantly in the peripheral nervous system and plays critical roles in axonal transport, neurite outgrowth, and neuronal survival. PRPH mutations have been implicated in amyotrophic lateral sclerosis (ALS) and neuronal intermediate filament inclusion disease (NIFID), highlighting its importance in neurodegenerative processes.
Peripherin is a 471-amino acid protein belonging to the type III intermediate filament family, which also includes vimentin, desmin, and glial fibrillary acidic protein (GFAP). Its structure consists of:
- Alpha-helical rod domain (approximately 310 residues): The central coiled-coil region responsible for dimerization and higher-order assembly
- Non-alpha helical head domain (N-terminal): Involved in filament assembly initiation
- Non-alpha helical tail domain (C-terminal): Regulates filament dynamics and interactions with binding partners
The protein forms homodimers that subsequently assemble into tetramers and higher-order filament structures, creating the intermediate filament network in neurons[2].
Peripherin serves multiple essential functions in neurons:
- Intermediate filament network: Provides structural support to neurons, maintaining axonal caliber and neuronal morphology
- Axonal transport: Serves as a tracks for organelle and protein transport via molecular motor proteins
- Synaptic function: Associates with synaptic vesicles and participates in neurotransmitter release
¶ Development and Maintenance
- Neurite outgrowth: Promotes axonal extension during development and regeneration[3]
- Axonal maintenance: Critical for long-term axonal integrity, particularly in peripheral neurons
- Response to injury: Upregulated following nerve injury, participating in regenerative processes
Peripherin forms heteropolymers with:
- Alpha-internexin (INA): Co-assembles in central nervous system neurons
- Neurofilament light chain (NFL/NEFL): Forms heterotetramers in peripheral neurons
- Neurofilament medium and heavy chains: Participates in neurofilament assembly
This ability to form heteropolymers allows fine-tuning of the intermediate filament network's mechanical properties[4].
Peripherin has been strongly linked to ALS pathogenesis:
- Genetic mutations: Frameshift mutations in PRPH (particularly p.Lys368Valfs*35) cause autosomal dominant ALS with a founder effect in Russian families[5]
- Protein aggregation: Mutant peripherin forms insoluble aggregates that accumulate in motor neurons, disrupting the cytoskeleton
- Inclusion body formation: Peripherin-positive inclusions are found in sporadic ALS cases, suggesting a common pathway[6]
- Axonal transport defects: Aggregation of peripherin disrupts axonal transport, leading to neurodegeneration
- Dysregulation of neurofilaments: Alters the stoichiometry of neurofilament assembly, contributing to axonal dysfunction
The mechanism involves toxic gain-of-function through aggregate formation, rather than loss of normal function.
- Rare neurodegenerative disorder: Characterized by frontotemporal dementia with movement abnormalities
- Inclusion formation: PRPH mutations lead to the formation of neuronal intermediate filament inclusions
- Clinical features: Early-onset frontotemporal dementia, pyramidal signs, and parkinsonism
- Pathology: Affects the frontal and temporal cortices, basal ganglia, and brainstem
- Peripheral neuropathy: Some PRPH variants are associated with hereditary peripheral neuropathies
- Axonal degeneration: Leads to distal muscle weakness and sensory loss
- Often in combination: With other intermediate filament mutations
- Alzheimer's Disease: Peripherin is found in some amyloid plaques and may participate in axonal pathology[7]
- Parkinson's Disease: Detected in Lewy bodies in some cases
- Aging: Peripherin accumulates in aged neurons, potentially contributing to age-related neurodegeneration
Peripherin shows a characteristic expression pattern:
- Dorsal root ganglion (DRG) sensory neurons
- Motor neurons (spinal cord and brainstem)
- Autonomic ganglion neurons (sympathetic and parasympathetic)
- Small unmyelinated C-fibers
- Peripheral nerve axons
- Some central nervous system neurons (mostly as heteropolymers with alpha-internexin)
- Neuroendocrine cells
- Certain glial cells (at low levels)
- Predominantly cytoplasmic
- Associated with the intermediate filament cytoskeleton
- Present in axons and dendrites
- Accumulates in aggregates under pathological conditions
Understanding peripherin's role in neurodegeneration opens therapeutic avenues:
- Aggregate prevention: Small molecules that prevent peripherin aggregation
- Gene therapy: Delivering wild-type PRPH or RNA interference for mutant alleles
- Axonal transport enhancement: Targeting downstream transport defects
- Neuroprotective strategies: Modulating downstream apoptotic pathways
- Biomarker development: Peripheral nerve proteins as disease biomarkers
- Gros-Louis F, et al. (2010). "A frameshift mutation in PRPH causes autosomal dominant ALS." Brain. DOI:10.1093/brain/awp329
- Portier MM, et al. (1999). "Peripherin in neuronal survival and axonal regeneration." Exp Neurol. PMID:10516475.
- McLean JR, et al. (2012). "Altered neurofilament expression and phosphorylation in models of ALS." J Neuropathol Exp Neurol. PMID:22975585.
- Nixon RA, et al. (1993). "The role of intermediate filaments in neuronal function." Prog Brain Res. PMID:8332766.
- Lavedan C, et al. (2002). "Identification of risk and age-at-onset genes for ALS." Am J Hum Genet. DOI:10.1086/338159
- Carpenter S, et al. (1988). "Peripherin in amyotrophic lateral sclerosis." Ann Neurol. PMID:3069255.
- Takahashi K, et al. (1991). "Peripherin in Alzheimer's disease." Acta Neuropathol. PMID:1751443.
The study of Prph Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Gros-Louis F, et al. (2010). "A frameshift mutation in PRPH causes autosomal dominant ALS." Brain. DOI:10.1093/brain/awp329 https://doi.org/10.1093/brain/awp329
[2] Portier MM, et al. (1999). "Peripherin in neuronal survival and axonal regeneration." Experimental Neurology. PMID:10516475. https://pubmed.ncbi.nlm.nih.gov/10516475/
[3] McLean JR, et al. (2012). "Altered neurofilament expression and phosphorylation in models of ALS." Journal of Neuropathology & Experimental Neurology. PMID:22975585. https://pubmed.ncbi.nlm.nih.gov/22975585/
[4] Nixon RA, et al. (1993). "The role of intermediate filaments in neuronal function." Progress in Brain Research. PMID:8332766. https://pubmed.ncbi.nlm.nih.gov/8332766/
[5] Lavedan C, et al. (2002). "Identification of risk and age-at-onset genes for ALS." American Journal of Human Genetics. DOI:10.1086/338159 https://doi.org/10.1086/338159
[6] Carpenter S, et al. (1988). "Peripherin in amyotrophic lateral sclerosis." Annals of Neurology. PMID:3069255. https://pubmed.ncbi.nlm.nih.gov/3069255/
[7] Takahashi K, et al. (1991). "Peripherin in Alzheimer's disease." Acta Neuropathologica. PMID:1751443. https://pubmed.ncbi.nlm.nih.gov/1751443/